Clinical Trial

Evaluation of Gait Impairment and Correlation in Patients With DCM

Study acronym: DCM-HFIMU
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 25, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate gait impairment in patients with Degenerative Cervical Myelopathy (DCM) before and after surgery using an inertial measurement unit (IMU) sensor. By comparing IMU-derived gait parameters with traditional clinical assessment tools (e.g., Modified Ashworth Scale, mJOA, and GRASSP), the study seeks to determine the effectiveness and reliability of IMU sensors for assessing and monitoring gait improvement and neurological recovery in DCM patients. This study is conducted outside the United States and does not involve interventions or devices subject to U.S. FDA regulation.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-12-03; most recent amendment 2025-06-20.
Trial Details
NCT Number NCT06719375
Lead Sponsor Pusan National University Yangsan Hospital
Conditions Myelopathy Cervical
Enrollment 30 participants
Start Date 2025-10-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-25